{"product_id":"hydrashift-2-4-daratumumab-immunofixation-interference-kit-4639","title":"HYDRASHIFT 2\/4 daratumumab Immunofixation Interference Kit","description":"\u003cp\u003eHYDRASHIFT 2\/4 daratumumab removes the daratumumab interference from serum immunofixation, so the therapeutic monoclonal antibody is no longer mistaken for a residual M-protein in treated myeloma patients. 20 tests per kit, run on HYDRASYS.\u003c\/p\u003e\u003ch2\u003eKey Benefits\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnique shift technology:\u003c\/strong\u003e HYDRASHIFT daratumumab and HYDRASHIFT isatuximab avoid daratumumab or isatuximab interference on HYDRAGEL IF tests.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrust in the results:\u003c\/strong\u003e HYDRASHIFT reduce the risk of incorrect IF interpretation to improve therapy monitoring.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy to implement:\u003c\/strong\u003e Fully integrated into IF protocol without sample pre-treatment for a standardized process compliant to IMWG guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFollow IMWG guidelines:\u003c\/strong\u003e Process compliant to IMWG guidelines to assess response to treatment in patient with Multiple Myeloma.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMain Characteristics\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTest Principle\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eHYDRASHIFT is an immunofixation procedure performed on HYDRAGEL IF 2\/4 gel and based on the creation of a mAb\/ anti mAb immune complex shift mAb drug (daratumumab or isatuximab) in alpha zone.\u003c\/p\u003e \u003cp\u003eThis complex is visible in the IgG and kappa immunofixation tracks. A negative HYDRASHIFT result demonstrates the absence of endogenous M-protein.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample Type\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSerum\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePerformances\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e\u003cem\u003e\u003cstrong\u003eSensitivity\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e \u003cp\u003eThe limit of immune complex visualized is 0.3 g\/L.\u003c\/p\u003e\u003ch2\u003eOrdering Information\u003c\/h2\u003e\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCat. No.\u003c\/th\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\u003ctr\u003e\n\u003ctd\u003e4639\u003c\/td\u003e\n\u003ctd\u003eHYDRASHIFT 2\/4 DARATUMUMAB (20)\u003c\/td\u003e\n\u003c\/tr\u003e\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Sebia","offers":[{"title":"Default Title","offer_id":67629802160207,"sku":"4639","price":0.0,"currency_code":"ILS","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0712\/0748\/5519\/files\/hydrahisft_visuel_web1.webp?v=1791284904","url":"https:\/\/www.danyel.co.il\/products\/hydrashift-2-4-daratumumab-immunofixation-interference-kit-4639","provider":"danyel biotech","version":"1.0","type":"link"}